SCHEDULE: Mobia Medical: Venture Partners Disclose Stake

U.S. Venture Partners and related entities have disclosed their beneficial ownership of Mobia Medical, Inc. common stock, representing a significant stake.

Summary

• This filing is a Schedule 13G, reporting beneficial ownership of Mobia Medical, Inc. common stock.
• U.S. Venture Partners XII, L.P. directly holds 1,906,809 shares, representing 5.7% of the class.
• Presidio Management Group XII, L.L.C. beneficially owns 3,626,826 shares (10.9%), including holdings from USVP XII, USVP XII-A, and USVP SFI.
• Casey M. Tansey, a director of Mobia Medical, beneficially owns 3,860,158 shares (11.6%), which includes direct and indirect holdings through management entities.
• The total outstanding shares of common stock as of June 1, 2026, were reported as 33,249,006.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting ownership stakes and not containing operational or financial performance updates.

Positives

• Significant investment by venture capital entities indicates potential confidence in the company's long-term prospects.
• The disclosure clearly outlines the ownership structure and beneficial interests of key investors.

Negatives

• The filing does not provide any operational or financial performance data, making it difficult to assess the company's current health.
• The complex ownership structure involving multiple entities and individuals could lead to confusion regarding ultimate control.

Risks

• Potential for future changes in ownership or strategy by the reporting persons.
• Concentration of ownership among a few entities could influence corporate decisions.

Future Outlook

This filing is a Schedule 13G and does not contain forward-looking statements or company guidance.

Management Comments

• Each reporting person disclaims beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.
• The reporting persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and venture capital firms to report significant ownership stakes in public companies. This filing indicates substantial investment by U.S. Venture Partners in Mobia Medical, Inc.

Stakeholder Impact

• Shareholders: The disclosure provides transparency on significant ownership, which can influence market perception.
• Management: The involvement of a board member (Casey M. Tansey) in the reporting entities highlights potential governance considerations.

Next Steps

• The reporting persons will continue to monitor their investment in Mobia Medical, Inc.
• Future filings will be made if ownership levels change significantly.

Key Dates

Keywords

Mobia Medical, Schedule 13G, Beneficial Ownership, U.S. Venture Partners, Presidio Management Group, Venture Capital, Common Stock, Ownership Stake